February 2026
The global blockchain-enabled clinical trial integrity market is driven by rising concerns over data fraud, protocol deviations, and lack of interoperability in traditional trial systems.
September 2026
The omics-based clinical trials market generated USD 38.61 billion in 2026, with prominent omics-based clinical trials market companies including Parexel International (MA) Corporation, Thermo Fisher Scientific Inc.
September 2026
The global clinical trials market size is calculated at USD 91.66 billion in 2026 and is projected to hit around USD 158.92 billion by 2035, with a solid CAGR of 6.15%.
September 2026
The global clinical trial patient recruitment services market size is estimated to hit around USD 2.29 billion by 2035 increasing from USD 1.15 billion in 2026, with a CAGR of 8.01%.
September 2026
The virtual clinical trials market size is calculated at USD 11.83 billion in 2026 and is projected to hit around USD 18.40 billion by 2035 with a CAGR of 5.03%.
September 2026
The clinical trial packaging market size is calculated at USD 4.04 billion in 2026 and is projected to hit around USD 9.12 billion by 2034 with a CAGR of 10.70%.
September 2026
The global clinical trial management system market size is expected to surge to around USD 7.28 billion by 2035 from USD 2.56 billion in 2026, with a CAGR of 12.36%.
September 2026
The global clinical trial supply and logistics market size reached USD 4.63 billion in 2026 and is projected to hit around USD 8.95 billion by 2035, with a CAGR of 7.63%.
September 2026
The global AI-based clinical trials solution provider market size is estimated to surpass around USD 20.17 billion by 2035 from USD 3.52 billion in 2026, at a CAGR of 21.49%.
September 2026
The mental health clinical trials market size was valued at USD 3.72 billion in 2026 and is projected to surge around USD 7.00 billion by 2034, with a CAGR of 8.24%.
September 2026
The neurology clinical trials market size was valued at USD 6.57 billion in 2026 and is projected to reach around USD 10.14 billion by 2034 with a CAGR of 5.58%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
September 2026
The U.S. clinical trial management system market size was evaluated at USD 910 million in 2026 and is predicted to hit around USD 2,400 million by 2034, growing at a CAGR of 12.79%.
September 2026
The biopharma clinical trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The generative AI in clinical trials market size was USD 303.39 billion in 2026, with leading generative AI in clinical trials market players including IBM, Microsoft, Google Health, IQVIA, Parexel, ICON plc.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The U.S. clinical trial supply and logistics market was worth USD 1.66 billion in 2026, with key U.S. clinical trial supply and logistics market players including Marken, World Courier, Fisher Clinical Services.
September 2026
The decentralized clinical trials in neurology market size reached USD 1.71 billion in 2026, with leading decentralized clinical trials in neurology market companies including IQVIA, ICON plc, Parexel, Medpace.
September 2026
The CNS clinical trials market size reached USD 9.33 billion in 2026, with leading CNS clinical trials market companies including IQVIA, ICON plc, Labcorp Drug Development, Syneos Health.
September 2026
The clinical trial labels market is growing with demand for accurate, compliant, and multilingual labeling solutions in global clinical research.
September 2026
The global clinical trial materials manufacturing market is driven by rising global trials, need for temperature-sensitive logistics, and quality manufacturing.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
August 2026
The U.S. clinical trials market size is valued at USD 47.18 billion in 2025 and is projected to hit around USD 88.16 billion by 2035 with a CAGR of 6.45%.
July 2026
The global AI in clinical trials market size was exhibited at USD 2.60 billion in 2025 and is projected to hit around USD 25.52 billion by 2035, with a remarkable CAGR of 25.66%.
July 2026
The global clinical trial imaging market size reached USD 2.35 billion in 2024 and is projected to hit around USD 5.45 billion by 2034, with a CAGR of 8.78%.
July 2026
The cloud-based clinical trial market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global medical device clinical trials market size was evaluated at USD 18.84 billion in 2026 and is predicted to hit around USD 32.25 billion by 2035, growing at a CAGR of 6.16%.
June 2026
The atopic dermatitis clinical trials market size is evaluated at USD 3.04 billion in 2025 and is expected to attain around USD 8.39 billion by 2035 with a CAGR of 10.69%.
May 2026
The clinical trial supplies market size was valued at USD 3.15 billion in 2025 and it is expected to Worth around USD 5.9 billion by 2035 with a CAGR of 6.48%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com